Huge negative change - Recensione dipendente - Director presso BeOne

1,0
4 mar 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

A majority of the people at BeOne are nice people and the office in San CArlos is pretty nice.

Svantaggi

Unfortunately the culture has changed so much. They are trying to be big pharama and it is a fail. The culture has become toxic. So toxic, many people are looking to leave or have been asked to leave. They are now scaling back on equity and bonuses were down this year, even though the earnings were finally decent. There is no promotions given except for certain men. Also, there is a launch this year, but then nothing for 3-4 years. the company is going to go through some tough times very soon.

Esplora altre recensioni su BeOne

5,0
24 apr 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Svantaggi

Fast timelines and global expansion may translate into heavy workload and urgency

5,0
22 apr 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

chance to make a bigger impact than at big pharma but not as risky as a small biotech or start up where the company can run out of funding, high pay, flexible hours

Svantaggi

longer work hours, off-hour calls with different regions depending on the role, experiences can vary by group

Vedi recensioni per: Utile|Valutazione|Data|Tutto